• Accueil >
  • Publications >
  • Intravenous high‐dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study

Intravenous high‐dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study

1 juil. 2021American Journal of Hematology

DOI : 10.1002/ajh.26199

Auteurs

Marion Lam, Valérie Touitou, Sylvain Choquet, Nathalie Cassoux, Hervé Ghesquières, Laurent Kodjikian, Anna Schmitt, Sarra Gattoussi, Émeline Tabouret, Magali Sampo, Marie Blonski, Karine Angioi‐Duprez, Roch Houot, Frédéric Mouriaux, Emmanuel Gyan, Marie‐Laure Le Lez, Marie‐Pierre Moles, Fabien Croisé, Adrien Chauchet, Claire Schwartz, Guido Ahle, Laurent Meyer, Rémy Gressin, Christophe Chiquet, Lucie Oberic, Priscille Ollé, Jean‐Pierre Marolleau, Benjamin Jany, Adrian Tempescul, Béatrice Cochener, Gandhi Damaj, Jean‐Claude Quintyn, Cécile Moluçon‐Chabrot, Eve Rousseau, Paul Franciane, Christelle Schneider, Hélène Massé, Jérôme Tamburini‐Bonnefoy, Antoine Brézin, Luc‐Matthieu Fornecker, Laurent Ballonzoli, Magali Le Garff‐Tavernier, Khê Hoang‐Xuan, Bahram Bodaghi, Carole Soussain, Caroline Houillier